SHIC investigates canine parvovirus 2 for potential risk to US swine

In October 2020, diagnostic laboratory sequencing of lung tissue from a US pig revealed the presence of canine parvovirus 2 (CPV2). The unexpected detection of CPV2 was assumed to be an incidental finding in lung tissue lacking significant lesions and not a contributor to disease. However, since this was the first known detection of CPV2 in swine, SHIC funded research to determine if CPV2 may be an emerging disease risk to US swine.

CPV2 is a non-enveloped single-stranded DNA virus which infects domestic dogs globally, resulting in gastrointestinal disease and immunosuppression. However, CPV2 originated from a cross-species transmission of feline parvovirus into dogs over 40 years ago and has since been detected in many wildlife species. Led by Dr. Ben Hause, an Assistant Professor at South Dakota State University, the SHIC-funded research project had three objectives to determine the cross-species transmission and pathogenesis risk to swine.

First, tissues previously submitted to the diagnostic lab from US swine were screened for the presence of CPV2 genome using PCR. Approximately 13% of tissues had CPV2 detected at relatively low DNA levels (mean Ct = 31). Second, serum samples previously submitted to the diagnostic lab from US swine were screened for the presence of CPV2 antibodies using hemagglutination inhibition assays. Approximately 66% of serum samples had CPV2 antibodies detected at low levels (most titers ≤ 80). Third, colostrum-deprived  one day old  neonatal pigs were inoculated through the oronasal route with CPV2 to assess their ability to replicate the virus and the ability of CPV2 to induce disease. Experimentally inoculated swine did not appear to develop productive CPV2 infections.

Overall, research determined that although CPV2 is capable of spillover into swine, the virus does not appear to be highly pathogenic to pigs. Continued vigilance of the industry is needed as mutations of CPV2 over time may alter the epidemiological situation and increase the disease risk to US swine.

SHIC, launched by the National Pork Board in 2015 solely with Pork Checkoff funding, continues to focus efforts on prevention, preparedness, and response to novel and emerging swine disease for the benefit of US swine health. As a conduit of information and research, SHIC encourages sharing of its publications and research. Forward, reprint, and quote SHIC material freely. SHIC is funded by America’s pork producers to fulfill its mission to protect and enhance the health of the US swine herd. For more information, visit http://www.swinehealth.org or contact Dr. Paul Sundberg at psundberg@swinehealth.org.

May 18, 2022

SHIC investigates canine parvovirus 2 for potential risk to US swine

In October 2020, diagnostic laboratory sequencing of lung tissue from a US pig revealed the presence of canine parvovirus 2 (CPV2). The unexpected detection of CPV2 […]
May 18, 2022

SHIC-Funded Study Looks to Other Industries for Infectious Aerosol Biocontainment Ideas

A project to evaluate technologies to prevent the spread of infectious bioaerosols is making progress. Led by Dr. Montse Torremorell at the University of Minnesota, the […]
April 29, 2022

May 2022 SHIC eNewsletter

SHIC-Led Research Builds Foundation of Knowledge for Pathogen Risk in Feed
SHIC Initiated Swine Disease Reporting System Continues to Expand with PCV2
SHIC-Funded Characterization of S. zooepidemicus Isolates from Indiana Complete
SHIC Talk
May Disease Monitoring Reports
April 22, 2022

SHIC-Led Research Builds Foundation of Knowledge for Pathogen Risk in Feed

From its inception in 2015, the Pork Checkoff-funded Swine Health Information Center (SHIC) has been a leader in enabling research priorities to identify the risk and […]
April 4, 2022

SHIC Updates PCV3 Fact Sheet and Pursues Case Definition

The Swine Heath Information Center has updated its porcine circovirus 3 Fact Sheet and begun a project with Iowa State University and the University of Minnesota […]